Opioid Prescribing
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
LabcorpPDMP Legal Mandate E-mail
Angeles TherapeuticsGuideline-Based
Human BioSciencesAcademic detailing
Clinical Trials (3)
Total enrollment: 8,575 patients across 3 trials
E-mails to Nudge Safer and Better-Informed Prescribing of Risky Drugs
Start: Jul 2024Est. completion: Sep 20257,872 patients
N/ACompleted
Postoperative Nudges to Reduce Opioid Prescribing
Start: Oct 2021Est. completion: Oct 2023640 patients
N/ACompleted
Effect of Academic Detailing to Reduce Opioid Prescribing in Dentistry
Start: Apr 2020Est. completion: May 202163 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.